Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris. (Q51771325)
Jump to navigation
Jump to search
scientific article published on 12 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris. |
scientific article published on 12 March 2009 |
Statements
Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris. (English)
1 reference
pemphigus vulgaris
1 reference
Rüdiger Eming
1 reference
Angela Nagel
1 reference
Eva Podstawa
1 reference
Markus Eickmann
1 reference
Hans-Helge Müller
1 reference
Michael Hertl
1 reference
12 March 2009
1 reference
129
1 reference
9
1 reference
2202-2210
1 reference
Identifiers
1 reference